Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: An open phase I/II trial in healthy adults in Russia (Q37713766)
Jump to navigation
Jump to search
scientific article published on 02 February 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: An open phase I/II trial in healthy adults in Russia |
scientific article published on 02 February 2017 |
Statements
1 reference
Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: An open phase I/II trial in healthy adults in Russia (English)
1 reference
O V Zubkova
A I Tukhvatulin
A S Dzharullaeva
N M Tukhvatulina
D V Shcheblyakov
M M Shmarov
E A Tokarskaya
Y V Simakova
D A Egorova
D N Scherbinin
A V Kostarnoy
P G Gancheva
T A Ozharovskaya
B V Belugin
L V Kolobukhina
V B Pantyukhov
S I Syromyatnikova
I V Shatokhina
T V Sizikova
I G Rumyantseva
A F Andrus
N V Boyarskaya
A N Voytyuk
V F Babira
S V Volchikhina
D A Kutaev
A N Bel'skih
K V Zhdanov
S M Zakharenko
2 February 2017
1 reference